Wellfully Ltd (wfl) Logo

Wellfully Ltd (WFL)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

WFL Chart

WFL's Principal Activity is the research and development for its Dermaportation and ETP transdermal drug delivery technologies.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) +340.23%
vs ASX 200 (1yr) +305.36%

Size

Market Capitalisation
ASX Rank 1956 of 2,560
Sector Rank 162 of 177

Key Information

Shares Issued
Sector Healthcare
Similar Companies CDY / ALT / NC6
EPS -$0.064
DPS $0.00
NTA per share $0.01

Broker Consensus

WFL is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Company Overview

Wellfully Limited (WFL, formerly OBJ Limited) is a science-based wellness company, offers own-brand, REDUIT and a portfolio of proprietary technologies and supports partners by providing IP-protected market exclusivity, expertise in magnetic array design, feasibility and efficacy, and claims testing, engineering and production.

Incorporation Details

Incorporated in NSW on 22/06/1992. Changed Industrial Classification from 226 - Miscellaneous Industrials to 183 - Telecommunications on 13/07/2001. Home branch changed from Sydney to Perth on 23/2/2004. Name changed to OBJ Limited.

Corporate Details

Head Office Leederville WA 6007
Website www.wellfully.net
Registry Automic Group
Auditor RSM Australia Partners
Date Listed 29 May 2000

Upcoming Calendar

Date Event
30/08/2021 Report (Prelim)
30/09/2021 Report (Annual)
28/02/2022 Report (Interim)

Dividend History

Ex-Date Amount Franking Gross Type Payable
03/03/2010 $0.02 100% $0.0286 Interim 31/03/2010
26/08/2009 $0.03 100% $0.0429 Final 15/09/2009
16/03/2009 $0.05 100% $0.0714 Interim 06/04/2009

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio --
DRP No
DRP Features -

Directors & Management

Directors & Management

Name Title Since Bio
Mr Paul Peros Chief Executive Officer Apr 2020
Mr Cameron Reynolds Non-Executive Director Jul 2018 Director Bio icon

Mr Cameron Reynolds

Non-Executive Director

Mr Reynolds is the President, Chief Executive Officer (CEO) and Director of VolitionRX, a biotech company which listed on the New York Stock Exchange (NYSE) in February 2015 after being founded by Mr Reynolds in 2010. He has experience in the management, structuring, and strategic planning of start-up companies and has held positions including CEO, Chief Financial Officer and Non-Executive Director of public and private enterprises.

Mr Antonio (Tony) Della Vergiliana Varano Non-Executive Director,Non-Executive Chairman May 2018 Director Bio icon

Mr Antonio (Tony) Della Vergiliana Varano

Non-Executive Director,Non-Executive Chairman

Mr Varano has more than 30 years experience across Australia, Europe and the USA, operating and managing successful entrepreneurial, corporate and investment pursuits. This experience has covered start up, funding and growth, corporate operations, executive management and business exits. His expertise spans retail, cosmetics, skincare, real estate, agriculture, publishing, construction, entertainment and the arts. New York-based, Mr Varano holds Board and investment positions in several companies he has either founded or invested in at an early stage. Mr Varano studied business at the Western Australian Institute of Technology.

Mr Steven Lorn Schapera Non-Executive Director Aug 2017 Director Bio icon

Mr Steven Lorn Schapera

Non-Executive Director

Mr Schapera founded the BECCA Cosmetic brand (www.beccacosmetics.com) and commercialised it into a range of cosmetic products that were distributed throughout Europe, Asia and North America. Mr Schapera guided BECCA from its infancy through to being a global player in the luxury cosmetic space. In 2016, BECCA was sold to Estee Lauder for more than US$230 million. Mr Schapera is Chairman of BECCA Holdings Pty. Ltd.; he serves as a non-executive Director on the Board of Invincible Brands GmbH., arguably Europe's most successful influencermarketing business, and recently assisted with their partial sale to Henkel. He is also Founder and Managing Director of London-based Lab Brands Limited and is a non-executive Director of Wild Nutrition Ltd, a fast-growing player in the vitamin and mineral supplement space.

Mr John Joseph Palermo Company Secretary May 2008
Mr Jeffrey David Edwards Managing Director Oct 2004 Director Bio icon

Mr Jeffrey David Edwards

Managing Director

Mr Edwards is responsible for Licensing and Partnering programs with Procter & Gamble and other partners, Intellectual Property and Technology Innovations. He is the recipient of an Australia Design award, and Product Innovation and Partnering awards from Procter & Gamble Consumer Products Divisions.

Director Transactions

WFL directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
22/12/20 Steven Schapera Buy +180,291 $0.14 $25,240 On-market trade
22/09/20 Antonio (Tony) Varano Transfer 1,125,000 $0.10 $112,500 Off-market transfer
22/09/20 Steven Schapera Transfer 1,125,000 $0.10 $112,500 Off-market transfer
19/08/20 Antonio (Tony) Varano Transfer 1,402,330 $0.015 $21,034 Off-market transfer
19/08/20 Antonio (Tony) Varano Transfer 1,402,330 $0.015 $21,034 Off-market transfer
19/08/20 Antonio (Tony) Varano Issued 66,667 $0.10 $6,666 Rights issue
19/08/20 Antonio (Tony) Varano Issued 1,402,330 $0.10 $140,233 Director remuneration
19/08/20 Steven Schapera Issued 2,250,000 $0.10 $225,000 Placement
19/08/20 Steven Schapera Issued 1,733,013 $0.10 $173,301 Director remuneration
19/08/20 Cameron Reynolds Issued 562,500 $0.10 $56,250 Director remuneration
30/04/20 Christopher Quirk Transfer 1,158,831 $0.015 $17,382 Off-market transfer
30/04/20 Christopher Quirk Transfer 1,158,831 $0.015 $17,382 Off-market transfer
09/10/18 Steven Schapera Buy +1,100,000 $0.022 $24,287 On-market trade
07/08/18 Steven Schapera Buy +2,459,999 $0.029 $70,880 On-market trade
15/05/18 Steven Schapera Buy +349,151 $0.027 $9,331 On-market trade
15/05/18 Steven Schapera Buy +300,000 $0.027 $8,100 On-market trade
09/05/18 Steven Schapera Buy +700,000 $0.027 $19,059 On-market trade
08/05/18 Steven Schapera Buy +1,366,000 $0.027 $37,193 On-market trade

Director Interests

The current holdings of WFL directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Steven Schapera 22/12/2020 N/A 3,499,504 N/A N/A
Antonio (Tony) Varano 22/09/2020 1,402,330 2,793,997 N/A N/A
Cameron Reynolds 19/08/2020 0 562,500 N/A N/A
Jeffrey Edwards 30/06/2020 N/A 2,021,550 N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Sep 24, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Via Pastura Limited 6,720,000 4.59%
Mr Danny Pavlovich <Pavlovich Family A/C> 3,825,000 2.61%
Sunset Capital Management Pty Ltd <Sunset Superfund A/C> 3,500,000 2.39%
RFID Systems Pty Ltd <The Rfid Consulting A/C> 2,950,000 2.01%
The Brand Laboratories Fz Llc 2,858,013 1.95%
Citicorp Nominees Pty Ltd 2,533,738 1.73%
Rokamaho Pty Ltd <Pumba Blossom A/C> 1,903,334 1.30%
Virtus Capital Pty Ltd 1,846,559 1.26%
Antonio Varano Della Vergiliana 1,402,330 0.96%
Jeb Holdings Pty Ltd <Edwards Family A/C> 1,371,886 0.94%
Jomima Pty Ltd <Internal Equity A/C> 1,207,180 0.82%
Dr Alok Jhamb 1,160,000 0.79%
Sabina Pty Ltd <Australian Enterprise A/C> 1,125,000 0.77%
J P Morgan Nominees Australia Pty Ltd 1,074,945 0.73%
Mr Peter Fedele 981,657 0.67%
HSBC Custody Nominees (Australia) Ltd 910,708 0.62%
Daughters & Co Pty Ltd <Daughters & Co A/C> 881,608 0.60%
Mr Jason Michael Harkess 820,000 0.56%
Mulloway Pty Ltd <John Hartley Poynton Fam A/C> 750,000 0.51%
Provendore Pty Ltd <The Wilks Super Fund A/C> 740,000 0.51%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 1,364 1,302 531 1,012 279 4,488

Substantial Shareholders

No Substantial Shareholders for WFL in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.